Volumetric-modulated arc therapy vs c-IMRT in esophageal cancer: A treatment planning comparison

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

527

HTML

3443

Figures (1-2)

202

Tables (1-5)

Sum=4268

Oct 7, 2012 (publication date) through May 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 7, 2012; 18(37): 5266-5275
Published online Oct 7, 2012. doi: 10.3748/wjg.v18.i37.5266

Table 2 Parameters used in normal tissue complication probability

TD5/5: Tolerance dose leading to 5% complication rates at 5 years; TD50/5: Tolerance dose leading to 50% complication rates at 5 years.

Citation: Yin L, Wu H, Gong J, Geng JH, Jiang F, Shi AH, Yu R, Li YH, Han SK, Xu B, Zhu GY. Volumetric-modulated arc therapy vs c-IMRT in esophageal cancer: A treatment planning comparison. World J Gastroenterol 2012; 18(37): 5266-5275
URL: https://www.wjgnet.com/1007-9327/full/v18/i37/5266.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i37.5266